April 07, 2021 10:07
The European Medicines Agency's investigation of "rare" blood clots linked to AstraZeneca's vaccine threatens to throw another spanner in the works of Korea's coronavirus inoculation schedule.
The Korean government has failed to secure adequate supplies of alternatives and currently relies on AstraZeneca vaccines to inoculate most people scheduled for their jabs in the second quarter.
Marco Cavaleri, the EMA head of vaccines, told Italy's Il Messaggero newspaper in an interview published Tuesday, "In my opinion, we can say it now, it is clear there is a link with the vaccine. But we still do not know what causes this reaction."
"In the next few hours, we will say that there is a connection, but we still have to understand how this happens," he added.
The EMA later clarified it is "still investigating" and hopes to make a statement by Friday.
In Korea, 67 percent of the 11.5 million people scheduled to be inoculated in the second quarter are to be given the AstraZeneca vaccine.
A government spokesman here said Korea will wait for the EMA's announcement before making its own decision.
- Copyright © Chosunilbo & Chosun.com